Vanguard Group’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28B | Sell |
|
|||||
|
2025
Q1 | $1.37B | Buy |
|
|||||
|
2024
Q4 | $1.57B | Buy |
|
|||||
|
2024
Q3 | $1.58B | Sell |
|
|||||
|
2024
Q2 | $1.41B | Sell |
|
|||||
|
2024
Q1 | $1.08B | Buy |
|
|||||
|
2023
Q4 | $1.03B | Buy |
|
|||||
|
2023
Q3 | $1.05B | Buy |
|
|||||
|
2023
Q2 | $1.02B | Buy |
|
|||||
|
2023
Q1 | $1.03B | Buy |
|
|||||
|
2022
Q4 | $1.25B | Buy |
|
|||||
|
2022
Q3 | $924M | Buy |
|
|||||
|
2022
Q2 | $1B | Buy |
|
|||||
|
2022
Q1 | $748M | Buy |
|
|||||
|
2021
Q4 | $899M | Buy |
|
|||||
|
2021
Q3 | $768M | Sell |
|
|||||
|
2021
Q2 | $753M | Buy |
|
|||||
|
2021
Q1 | $687M | Buy |
|
|||||
|
2020
Q4 | $602M | Buy |
|
|||||
|
2020
Q3 | $392M | Sell |
|
|||||
|
2020
Q2 | $488M | Sell |
|
|||||
|
2020
Q1 | $393M | Buy |
|
|||||
|
2019
Q4 | $357M | Buy |
|
|||||
|
2019
Q3 | $311M | Sell |
|
|||||
|
2019
Q2 | $311M | Buy |
|
|||||
|
2019
Q1 | $464M | Buy |
|
|||||
|
2018
Q4 | $426M | Buy |
|
|||||
|
2018
Q3 | $483M | Buy |
|
|||||
|
2018
Q2 | $420M | Buy |
|
|||||
|
2018
Q1 | $405M | Buy |
|
|||||
|
2017
Q4 | $524M | Buy |
|
|||||
|
2017
Q3 | $415M | Sell |
|
|||||
|
2017
Q2 | $494M | Buy |
|
|||||
|
2017
Q1 | $512M | Buy |
|
|||||
|
2016
Q4 | $506M | Sell |
|
|||||
|
2016
Q3 | $424M | Sell |
|
|||||
|
2016
Q2 | $385M | Buy |
|
|||||
|
2016
Q1 | $397M | Buy |
|
|||||
|
2015
Q4 | $526M | Buy |
|
|||||
|
2015
Q3 | $412M | Sell |
|
|||||
|
2015
Q2 | $553M | Buy |
|
|||||
|
2015
Q1 | $545M | Buy |
|
|||||
|
2014
Q4 | $390M | Buy |
|
|||||
|
2014
Q3 | $381M | Buy |
|
|||||
|
2014
Q2 | $250M | Sell |
|
|||||
|
2014
Q1 | $281M | Buy |
|
|||||
|
2013
Q4 | $326M | Buy |
|
|||||
|
2013
Q3 | $217M | Buy |
|
|||||
|
2013
Q2 | $174M | Buy |
|